See also this year's filing and all EDGAR filings for this company.
PDF Report 0001261249_2023_AGILE_THERAPEUTICS_INC.pdf
Logs
info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001261249, AGILE THERAPEUTICS INC
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 11,358,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 177,000 |
3 | remainder_Assets | 2,707,000 |
4 | LiabilitiesCurrent | 13,387,000 |
5 | LiabilitiesNoncurrent | 466,000 |
6 | remainder_Liabilities | 5,934,000 |
7 | CostOfGoodsAndServicesSold | 6,836,000 |
8 | SellingGeneralAndAdministrativeExpense | 11,860,000 |
9 | ResearchAndDevelopmentExpense | 3,253,000 |
10 | remainder_Expenses | 36,816,000 |
11 | remainder_Revenues | 10,884,000 |
12 | remainder_NetIncome | 22,469,000 |
13 | remainder_ComprehensiveNetIncome | 0 |
yvar | yval | |
---|---|---|
0 | Assets | 14,242,000 |
1 | Liabilities | 19,787,000 |
2 | Expenses | 58,765,000 |
3 | Revenues | 10,884,000 |
4 | StockholdersEquity | -5,545,000 |
5 | NetIncome | -25,412,000 |
6 | ComprehensiveNetIncome | -25,412,000 |
7 | BaseVar | 63,073,500 |
8 | EconomicCapitalRatio | -2.05 |